549
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Human papillomavirus genotypes and infection among women in Changzhou, China

& ORCID Icon
Pages 1884-1888 | Received 09 Feb 2019, Accepted 21 Apr 2019, Published online: 22 May 2019

References

  • Acevedo-Fontanez AI, Suarez E, Torres Cintron CR, Ortiz AP. Risk of anal cancer in women with a human papillomavirus-related gynecological neoplasm: puerto Rico 1987-2013. J Low Genit Tract Dis. 2018;22(3):225–30. doi:10.1097/LGT.0000000000000395.
  • Adnan Ali SM, Awan MS, Atif S, Ali N, Mirza Y. Correlation of human papillomavirus infection and clinical parameters with five-year survival in oral squamous cell carcinoma. J Laryngol Otol. 2018;132(7):628–35. doi:10.1017/S0022215118000361.
  • Mizukami A, Kaise T, Van Kriekinge G. Resource use and cost of treating human papillomavirus-related lesions in Japanese women. Value Health Reg Issues. 2018;15:56–62. doi:10.1016/j.vhri.2017.07.009.
  • Bretagne CH, Jooste V, Guenat D, Riethmuller D, Bouvier AM, Bedgedjian I, Prétet JL, Valmary-Degano S, Mougin C. Prevalence and distribution of HPV genotypes and cervical-associated lesions in sexually active young French women following HPV vaccine. J Gynecol Obstet Hum Reprod. 2018;47:525–31. doi:10.1016/j.jogoh.2018.05.011.
  • Ceccarelli G, Cavallari EN, Savinelli S, Bianchi L, Pierangeli A, Vullo F, Ciardi A, D‘Ettorre G. Clearance of human papillomavirus related anal condylomas after oral and endorectal multistrain probiotic supplementation in an HIV positive male: A case report. Medicine (Baltimore). 2018;97:e0329. doi:10.1097/MD.0000000000010329.
  • Fuller C, Hudgins E, Finelt N. Human-papillomavirus-related disease in pediatrics. Curr Opin Pediatr. 2018;30:169–74. doi:10.1097/MOP.0000000000000561.
  • Li H, Torabi SJ, Yarbrough WG, Mehra S, Osborn HA, Judson B. Association of human papillomavirus status at head and neck carcinoma subsites with overall survival. JAMA Otolaryngol Head Neck Surg. 2018;144(6):519–25. doi:10.1001/jamaoto.2018.0395.
  • Zenga J, Pipkorn P, Graboyes EM, Martin EJ, Rich JT, Moore EJ, Haughey BH, Jackson RS. Oncologic outcomes of extended neck dissections in human papillomavirus-related oropharyngeal squamous cell carcinoma. Head Neck. 2018;40:955–62. doi:10.1002/hed.25044.
  • Zeferino LC, Bastos JB, Vale D, Zanine RM, Melo Y, Primo WQSP, Corrêa FM, Val ICCD, Russomano F. Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil. Rev Bras Ginecol Obstet. 2018;40(6):360–68. doi:10.1055/s-0038-1657754.
  • Long W, Yang Z, Li X, Chen M, Liu J, Zhang Y, Sun X. HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix. Virol J. 2018;15:94. doi:10.1186/s12985-018-1003-x.
  • Serra I, Araujo ED, Barros GS, Santos F, Gurgel RQ, Batista MVA. Prevalence of human papillomavirus types associated with cervical lesions in Sergipe state, Northeastern Brazil: high frequency of a possibly carcinogenic type. Epidemiol Infect. 2018;146:1184–93. doi:10.1017/S095026881800122X.
  • Orosco RK, Califano JA. HPV status, like politics, is local-evaluating p16 staining and a new staging system in a Dutch cohort of oropharynx cancer. Ann Oncol. 2018;29:1089–90. doi:10.1093/annonc/mdx807.
  • Flanagan MB. Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening in the United States: is It Time?. Arch Pathol Lab Med. 2018;142:688–92. doi:10.5858/arpa.2018-0001-RA.
  • Mena M, Taberna M, Tous S, Marquez S, Clavero O, Quiros B, Lloveras B, Alejo M, Leon X, Quer M, et al. Double positivity for HPV-DNA/p16(ink4a) is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients. Oral Oncol. 2018;78:137–44. doi:10.1016/j.oraloncology.2018.01.010.
  • Huang SH, O‘Sullivan B, Waldron J. The current state of biological and clinical implications of human papillomavirus-related oropharyngeal cancer. Semin Radiat Oncol. 2018;28:17–26. doi:10.1016/j.semradonc.2017.08.007.
  • Williamson AL, Garland S, Palefsky J, Rybicki E, Stanley M, de Sanjose S. The Cape Town declaration on human papillomavirus related disease. Papillomavirus Res. 2018;5:59–60. doi:10.1016/j.pvr.2017.12.003.
  • Vazquez-Otero C, Vamos CA, Thompson EL, Merrell LK, Griner SB, Kline NS, Catalanotto FA, Giuliano AR, Daley EM. Assessing dentists’ human papillomavirus-related health literacy for oropharyngeal cancer prevention. J Am Dent Assoc. 2018;149:9–17. doi:10.1016/j.adaj.2017.08.021.
  • Stiebing BN, Rosado FG, Vos JA. Human papillomavirus-related malignancies in the setting of posttransplantation immunosuppression. Arch Pathol Lab Med. 2018;142:711–14. doi:10.5858/arpa.2017-0586-RA.
  • Siddiq S, Cartlidge D, Stephen S, Sathasivam HP, Fox H, O’Hara J, Meikle D, Iqbal MS, Kelly CG, Robinson M, et al. Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with high risk human papillomavirus related squamous cell cancer. Eur Arch Otorhinolaryngol. 2018;275:1853–60. doi:10.1007/s00405-018-4968-6.
  • Shah AA, Lamarre ED, Bishop JA. Human papillomavirus-related multiphenotypic sinonasal carcinoma: A case report documenting the potential for very late tumor recurrence. Head Neck Pathol. 2018;12(4):623–28. doi:10.1007/s12105-018-0895-5.
  • Osazuwa-Peters N, Arnold LD, Loux TM, Varvares MA, Schootman M. Factors associated with increased risk of suicide among survivors of head and neck cancer: A population-based analysis. Oral Oncol. 2018;81:29–34. doi:10.1016/j.oraloncology.2018.03.017.
  • Ozkaya O, Karsidag S, Canli M, Soydan T, Sakiz D. A rare anatomical location of human papillomavirus-related penile warty carcinoma: simultaneous axillary involvement. Indian J Dermatol Venereol Leprol. 2018;84:336–38.
  • Zhao P, Liu S, Zhong Z, Hou J, Lin L, Weng R, Su L, Lei N, Hou T, Yang H. Prevalence and genotype distribution of human papillomavirus infection among women in northeastern Guangdong Province of China. BMC Infect Dis. 2018;18:204. doi:10.1186/s12879-018-3109-6.
  • Wang J, Tang D, Wang J, Zhang Z, Chen Y, Wang K, Zhang X, Ma C. Genotype distribution and prevalence of human papillomavirus among women with cervical cytological abnormalities in Xinjiang, China. Hum Vaccin Immunother. 2019. doi:10.1080/21645515.2019.1578598.
  • Herrero R. Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types. J Infect Dis. 2009;199:919–22. doi:10.1086/598985.
  • Owosho AA, Wiley R, Stansbury T, Gbadamosi SO, Js R. Trends in human papillomavirus-related oropharyngeal squamous cell carcinoma incidence, Vermont 1999-2013. J Community Health. 2018;43(4):731–37. doi:10.1007/s10900-018-0477-1.
  • Robadi IA, Pharaon M, Ducatman BS. The importance of high-risk human papillomavirus types other than 16 and 18 in cervical neoplasia. Arch Pathol Lab Med. 2018;142:693–95. doi:10.5858/arpa.2017-0563-RA.
  • Kaliff M, Sorbe B, Mordhorst LB, Helenius G, Karlsson MG, Lillsunde-Larsson G. Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapy. Oncotarget. 2018;9:18786–96. doi:10.18632/oncotarget.v9i27.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.